ACCENT II - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long Term Treatment of Patients With Fistulizing CROHN'S Disease
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004623/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A study of infliximab in patients with Fistulizing Crohn's Disease
提供机构：
Vivli
创建时间：
2019-09-19
